vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and BALCHEM CORP (BCPC). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $11.9M, roughly 22.2× ASCENT INDUSTRIES CO.). BALCHEM CORP runs the higher net margin — 14.9% vs -8.8%, a 23.6% gap on every dollar of revenue. On growth, ASCENT INDUSTRIES CO. posted the faster year-over-year revenue change (13.3% vs 9.8%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs -34.9%).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
ACNT vs BCPC — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $263.6M |
| Net Profit | $-1.0M | $39.2M |
| Gross Margin | 14.6% | 35.6% |
| Operating Margin | -21.0% | 19.8% |
| Net Margin | -8.8% | 14.9% |
| Revenue YoY | 13.3% | 9.8% |
| Net Profit YoY | -1.2% | 16.8% |
| EPS (diluted) | $-0.11 | $1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | $263.6M | ||
| Q3 25 | $19.7M | $267.6M | ||
| Q2 25 | $18.7M | $255.5M | ||
| Q1 25 | $24.7M | $250.5M | ||
| Q4 24 | $10.5M | $240.0M | ||
| Q3 24 | $20.9M | $239.9M | ||
| Q2 24 | $21.5M | $234.1M | ||
| Q1 24 | $28.0M | $239.7M |
| Q4 25 | $-1.0M | $39.2M | ||
| Q3 25 | $-2.1M | $40.3M | ||
| Q2 25 | $6.3M | $38.3M | ||
| Q1 25 | $-2.3M | $37.1M | ||
| Q4 24 | $-1.0M | $33.6M | ||
| Q3 24 | $-6.2M | $33.8M | ||
| Q2 24 | $-926.0K | $32.1M | ||
| Q1 24 | $-5.5M | $29.0M |
| Q4 25 | 14.6% | 35.6% | ||
| Q3 25 | 29.7% | 35.7% | ||
| Q2 25 | 26.1% | 36.4% | ||
| Q1 25 | 19.3% | 35.2% | ||
| Q4 24 | 24.3% | 36.0% | ||
| Q3 24 | 14.4% | 35.6% | ||
| Q2 24 | 13.1% | 35.5% | ||
| Q1 24 | 8.3% | 34.0% |
| Q4 25 | -21.0% | 19.8% | ||
| Q3 25 | -4.1% | 20.4% | ||
| Q2 25 | -14.4% | 20.1% | ||
| Q1 25 | -4.2% | 20.4% | ||
| Q4 24 | -25.4% | 19.8% | ||
| Q3 24 | -9.4% | 20.0% | ||
| Q2 24 | -8.6% | 19.6% | ||
| Q1 24 | -15.5% | 17.4% |
| Q4 25 | -8.8% | 14.9% | ||
| Q3 25 | -10.6% | 15.1% | ||
| Q2 25 | 33.7% | 15.0% | ||
| Q1 25 | -9.3% | 14.8% | ||
| Q4 24 | -9.8% | 14.0% | ||
| Q3 24 | -29.5% | 14.1% | ||
| Q2 24 | -4.3% | 13.7% | ||
| Q1 24 | -19.7% | 12.1% |
| Q4 25 | $-0.11 | $1.21 | ||
| Q3 25 | $-0.22 | $1.24 | ||
| Q2 25 | $0.65 | $1.17 | ||
| Q1 25 | $-0.23 | $1.13 | ||
| Q4 24 | $-0.11 | $1.03 | ||
| Q3 24 | $-0.61 | $1.03 | ||
| Q2 24 | $-0.09 | $0.98 | ||
| Q1 24 | $-0.54 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | $74.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.0M | $1.3B |
| Total Assets | $111.9M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | $74.6M | ||
| Q3 25 | $58.0M | $65.1M | ||
| Q2 25 | $60.5M | $65.4M | ||
| Q1 25 | $14.3M | $49.9M | ||
| Q4 24 | $16.1M | $49.5M | ||
| Q3 24 | $8.5M | $73.7M | ||
| Q2 24 | $3.6M | $63.7M | ||
| Q1 24 | $1.3M | $60.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.0M | $1.3B | ||
| Q3 25 | $87.1M | $1.3B | ||
| Q2 25 | $89.7M | $1.3B | ||
| Q1 25 | $91.2M | $1.2B | ||
| Q4 24 | $93.5M | $1.1B | ||
| Q3 24 | $94.7M | $1.2B | ||
| Q2 24 | $101.0M | $1.1B | ||
| Q1 24 | $102.0M | $1.1B |
| Q4 25 | $111.9M | $1.7B | ||
| Q3 25 | $119.9M | $1.7B | ||
| Q2 25 | $122.6M | $1.7B | ||
| Q1 25 | $152.5M | $1.6B | ||
| Q4 24 | $147.3M | $1.6B | ||
| Q3 24 | $148.6M | $1.6B | ||
| Q2 24 | $158.2M | $1.6B | ||
| Q1 24 | $161.0M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $67.3M |
| Free Cash FlowOCF − Capex | $-196.0K | — |
| FCF MarginFCF / Revenue | -1.7% | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | $67.3M | ||
| Q3 25 | $1.3M | $65.6M | ||
| Q2 25 | $-1.4M | $47.3M | ||
| Q1 25 | $-700.0K | $36.5M | ||
| Q4 24 | $8.8M | $52.3M | ||
| Q3 24 | $3.4M | $51.3M | ||
| Q2 24 | $2.2M | $45.0M | ||
| Q1 24 | $263.0K | $33.4M |
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $25.0K | — |
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | -0.22× | 1.23× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | — | 1.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
Segment breakdown not available.
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
